Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, Kimia Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 13, 2020 at 2.00 pm at Corporate Office of the Company, 974, 9thFloor, Aggarwal Millenium Tower-II, Netaji Subhash Place, Pitampura, New Delhi-110034, to consider & approve the Un-Audited Financial Results (Standalone) for the third quarter and nine month ended on December 31st, 2020. Further informed that the Trading Window for dealing In the Equity Shares of the Company by Designated Persons (and their Immediate relatives) has already been closed with effective from 1st January, 2020 up to the completion of 48 hours after the declaration of unaudited Financial Results for the 3rd quarter ended 31st December 2019 to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
